GR862021B - Process for obtaining aminoalcohols peptidic derivatives containing a tetrasubstituted carbon atom as inhibitors of renine and acid proteases - Google Patents

Process for obtaining aminoalcohols peptidic derivatives containing a tetrasubstituted carbon atom as inhibitors of renine and acid proteases

Info

Publication number
GR862021B
GR862021B GR862021A GR860102021A GR862021B GR 862021 B GR862021 B GR 862021B GR 862021 A GR862021 A GR 862021A GR 860102021 A GR860102021 A GR 860102021A GR 862021 B GR862021 B GR 862021B
Authority
GR
Greece
Prior art keywords
carbon atom
renine
aminoalcohols
inhibitors
obtaining
Prior art date
Application number
GR862021A
Other languages
Greek (el)
Inventor
Wagnon Jean
Guegan Remy
Lacour Colette
Nisato Dino
Original Assignee
Sanofi Sa
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa, Inst Nat Sante Rech Med filed Critical Sanofi Sa
Publication of GR862021B publication Critical patent/GR862021B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/86—Renin inhibitors

Abstract

The present invention relates to peptide amino-alcohol derivatives containing a tetra substituted carbon atom. Said peptides inhibit the renin and acid proteases. The invention also relates to the process for their obtention and to pharmaceutical compositions.
GR862021A 1985-07-31 1986-07-30 Process for obtaining aminoalcohols peptidic derivatives containing a tetrasubstituted carbon atom as inhibitors of renine and acid proteases GR862021B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8511728A FR2585708B1 (en) 1985-07-31 1985-07-31 RESIN AND ACID PROTEIN INHIBITOR AMINOALCOHOL DERIVATIVES, PREPARATION METHOD THEREOF AND THERAPEUTIC APPLICATION THEREOF

Publications (1)

Publication Number Publication Date
GR862021B true GR862021B (en) 1986-12-31

Family

ID=9321828

Family Applications (1)

Application Number Title Priority Date Filing Date
GR862021A GR862021B (en) 1985-07-31 1986-07-30 Process for obtaining aminoalcohols peptidic derivatives containing a tetrasubstituted carbon atom as inhibitors of renine and acid proteases

Country Status (17)

Country Link
US (1) US4840935A (en)
EP (1) EP0211744B1 (en)
JP (1) JP2505164B2 (en)
KR (1) KR930008111B1 (en)
AT (1) ATE70067T1 (en)
AU (1) AU600907B2 (en)
CA (1) CA1293839C (en)
DE (1) DE3682721D1 (en)
DK (1) DK172011B1 (en)
ES (1) ES2001863A6 (en)
FR (1) FR2585708B1 (en)
GR (1) GR862021B (en)
IE (1) IE59400B1 (en)
IL (1) IL79442A (en)
NZ (1) NZ217007A (en)
PT (1) PT83045B (en)
ZA (1) ZA865696B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ222755A (en) * 1986-12-23 1989-11-28 Warner Lambert Co Renin inhibiting acyl peptide derivatives containing two to four amino acid residues, and pharmaceutical compositions
DE3815913A1 (en) * 1988-05-10 1989-11-23 Sandoz Ag NEW RENINHERMERS, PROCESS FOR THEIR PRODUCTION AND THEIR USE
DE3841520A1 (en) * 1988-12-09 1990-06-13 Hoechst Ag ENZYME-INFRINGING DERIVATIVES OF DIPEPTIDES, METHOD FOR THE PRODUCTION THEREOF, METHODS CONTAINING THEM AND THEIR USE
FR2646354B1 (en) * 1989-04-27 1994-06-10 Sanofi Sa USE OF ACID PROTEASE INHIBITOR PEPTIDES FOR THE PREPARATION OF MEDICINES USEFUL FOR THE TREATMENT OF VIRAL DISEASES
FR2647675B1 (en) * 1989-06-05 1994-05-20 Sanofi USE OF A STATINE DERIVATIVE IN THE TREATMENT OF EYE CONDITIONS
JPH0765456B2 (en) * 1989-12-09 1995-07-19 株式会社奥村組 How to build an expanded tunnel section
JPH0768844B2 (en) * 1990-08-24 1995-07-26 鉄建建設株式会社 Widening method of shield tunnel
US5672717A (en) * 1993-10-26 1997-09-30 Iowa State University Research Foundation, Inc. Preparation of pyrrol and oxazole compounds; formation of porphyrins and C-acyl-α-amino acid esters therefrom
US5367084A (en) * 1993-10-26 1994-11-22 Iowa State University Research Foundation, Inc. Preparation of pyrrol and oxazole compounds: formation of porphyrins and c-acyl-α-amino acid esters therefrom
US5804560A (en) * 1995-01-06 1998-09-08 Sibia Neurosciences, Inc. Peptide and peptide analog protease inhibitors
US6017887A (en) * 1995-01-06 2000-01-25 Sibia Neurosciences, Inc. Peptide, peptide analog and amino acid analog protease inhibitors
US5833946A (en) * 1995-06-06 1998-11-10 Bayer Corporation Dissemination of fungal infections: animal model and method of prophylaxis
MXPA03000397A (en) * 2000-07-13 2003-05-27 Sankyo Co Amino alcohol derivatives.
WO2005105069A1 (en) * 2004-04-26 2005-11-10 Alcon, Inc. Statins for the treatment of ocular hypertension and glaucoma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1245217A (en) * 1981-12-10 1988-11-22 Joshua S. Boger Renin inhibitory peptides having phe su13 xx deletion
US4595677A (en) * 1982-12-03 1986-06-17 Ciba-Geigy Corporation Substituted tetrapeptides
US4668663A (en) * 1984-03-27 1987-05-26 Merck & Co., Inc. Renin inhibitors containing homophe8
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
US4636491A (en) * 1984-03-27 1987-01-13 Merck & Co., Inc. Renin inhibitory peptides having improved solubility
DE3418491A1 (en) * 1984-05-18 1985-11-21 Merck Patent Gmbh, 6100 Darmstadt DIAMINO ACID DERIVATIVES
CA1286846C (en) * 1985-02-12 1991-07-23 Catherine Cazaubon Peptide derivatives which inhibit renin and acid proteases

Also Published As

Publication number Publication date
DK364486D0 (en) 1986-07-31
IE862031L (en) 1987-01-31
DK172011B1 (en) 1997-09-15
JPS6229596A (en) 1987-02-07
CA1293839C (en) 1991-12-31
IE59400B1 (en) 1994-02-23
NZ217007A (en) 1988-06-30
EP0211744A1 (en) 1987-02-25
KR930008111B1 (en) 1993-08-26
ES2001863A6 (en) 1988-07-01
EP0211744B1 (en) 1991-12-04
FR2585708B1 (en) 1989-07-07
KR880001697A (en) 1988-04-26
JP2505164B2 (en) 1996-06-05
PT83045A (en) 1986-08-01
US4840935A (en) 1989-06-20
AU6052086A (en) 1987-02-05
PT83045B (en) 1988-07-01
ZA865696B (en) 1987-03-25
DE3682721D1 (en) 1992-01-16
IL79442A0 (en) 1986-10-31
AU600907B2 (en) 1990-08-30
IL79442A (en) 1991-06-10
FR2585708A1 (en) 1987-02-06
DK364486A (en) 1987-02-01
ATE70067T1 (en) 1991-12-15

Similar Documents

Publication Publication Date Title
GR862021B (en) Process for obtaining aminoalcohols peptidic derivatives containing a tetrasubstituted carbon atom as inhibitors of renine and acid proteases
NZ214122A (en) Analgesic dynorphin-like hepta and octa and nona and deca peptides
PT87652A (en) PROCESS FOR THE PREPARATION OF PEPTIDE BOBONIC ACID INHIBITORS OF TRYPSIN-LIKE PROTEASES
IE901673L (en) Enzymatic removal of a protein amino-terminal sequence
PT76267A (en) PROCESS FOR OBTAINING COMPOUNDS DERIVED FROM 3-HYDROXYBU-TANOIC ACID AND PROCESS FOR OBTAINING PHARMACEUTICAL COMPOSITIONS CONTAINING 3-HYDROXYBUTANOIC ACID OR A SALT DERIVED THEREFROM
GR860398B (en) Process for obtaining peptidic derivatives of renine inhibitors and proteases acids
PT75652B (en) Process for preparing renin inhibitory peptides
DE3360282D1 (en) Amino acid preparations containing glutaminic residues
GB2320248A (en) Method for preparing omega-aminoalkanoic acid derivatives from cycloalkanones
HUT38105A (en) Process for preparing new renine inhibitor peptides and pharmaceutical compositions containing such a peptide as active substance
HU905859D0 (en) Process for producing amino acid derivatives and pharmaceutical preparatives containing them
HU904201D0 (en) Process for producing peptides with haemoregulating effect and pharmaceutical preparatives containing these compounds
HUT53664A (en) Process for producing enzyme inhibiting amino acid derivatives and pharmaceutical compositions comprising such compounds as active ingredient
IL83775A (en) Amino acid esters and amides of fumaric acid and pharmaceutical compositions containing them for use in the treatment of psoriasis
IL64790A (en) Process for the preparation of compounds containing carboxylic acid amide groups,in particular of peptides
ATE46347T1 (en) IMMUNOSTIMULATING PEPTIDES.
YU194785A (en) New industrial process for synthesis of n-/(1[alyl-2[-pyrolidinyle) methyl/-2-metoxy-4,5-azimido-benzamide
YU180585A (en) Process for obtaining metalohelate of amino acids
IE842214L (en) Process for synthesis of peptide using¹thioxanthylmethyloxycarbonyl dioxides